Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
While the therapy is still undergoing clinical evaluation, the success of these early treatments signals a transformative future in diabetes care
BPC-157 & TB-500 CAPSULE SET: This research set combines BPC-157 (250mcg per capsule) and TB-500 (500mcg per capsule), two synthetic peptides studied for their roles in angiogenesis, actin regulation, tissue remodeling, and cellular signaling
In combination, BPC-157 and TB-500 provide a research framework for examining how peptide signaling influences cellular migration, vascular communication, and structural tissue organization in skeletal muscle models
[DOI] [PMC free article] [PubMed] [Google Scholar] Chen Q, Miller LJ, Dong M
Maintenance phase: After the loading phase, dosing typically drops to 2 mg every one to two weeks
Research Summary The gastrointestinal tract has been the most thoroughly investigated context for BPC-157 research, which is fitting given the peptides gastric origins
